Companies don't normally price US IPOs during holiday weeks, but two deals are scheduled for the week ahead. Read more here.

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

US multinational Honeywell is planning to file draft IPO papers for its quantum computing unit, Quantinuum, with the US securities regulator. Timings for the filing were not disclosed, and the company ...

Their transaction announced Tuesday has multiple moving parts to it, starting with the Defense Department’s agreement to ...

In a first-of-its-kind partnership, the Defense Department is taking a $1 billion stake in the business ahead of an initial ...

Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted radiation cancer treatments.

Good afternoon, and welcome to Phoenix Education Partners First Quarter Fiscal 2026 Earnings Conference Call. Today’s call is ...

OS Animal Health (OSAH), a wholly-owned subsidiary of OS Therapies (OSTX), targeting Initial Public Offering (IPO) on NYSE American or Nasdaq Capital Markets national stock exchange in the first half ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

The Bulls N’ Bears ASX Runner of the Week is…biopharma minnow Zelira Therapeutics, which landed a US$33 million funding deal to fast-track its autism drug towards FDA approval.

Unity Metals (ASX:UM1) has begun trading on the Australian Securities Exchange (ASX), following completion of an initial ...

Industrial company Honeywell ​said on Wednesday it plans for its ‌majority-owned quantum computing unit Quantinuum to ...